Spots Global Cancer Trial Database for previously untreated

Every month we try and update this database with for previously untreated cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma	NCT01335399	Multiple Myelom...	Lenalidomide Dexamethasone Dexamethasone Dexamethasone Dexamethasone Elotuzumab (BMS... Elotuzumab (BMS...	18 Years -	Bristol-Myers Squibb
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)	NCT01160354	Acute Myelogeno...	Plerixafor Clofarabine	60 Years -	M.D. Anderson Cancer Center
A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients	NCT00201825	Lung Cancer Non-Small-Cell ...	Capecitabine Docetaxel	18 Years -	Ohio State University Comprehensive Cancer Center
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)	NCT02412371	Non-small Cell ...	Paclitaxel Placebo for Vel... Carboplatin Veliparib Radiotherapy	18 Years -	AbbVie
A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)	NCT02391545	CD20+ Follicula...	Duvelisib Rituximab Obinutuzumab	18 Years -	SecuraBio
Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer	NCT00881296	Non-Small Cell ...	gemcitabine and... Gemcitabine	76 Years -	Hamamatsu University
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer	NCT00752115	Non-small Cell ...	sildenafil placebo paclitaxel (tax... carboplatin (pa...	40 Years - 75 Years	Hamamatsu University
Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer	NCT02305758	Untreated Metas...	Veliparib Placebo Modified FOLFIR... FOLFIRI Bevacizumab Fluorouracil in...	18 Years - 99 Years	AbbVie
Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)	NCT01160354	Acute Myelogeno...	Plerixafor Clofarabine	60 Years -	M.D. Anderson Cancer Center
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)	NCT04301739	Triple Negative...	HLX10 nab-paclitaxel,... Placebo	18 Years - 70 Years	Shanghai Henlius Biotech
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer	NCT00752115	Non-small Cell ...	sildenafil placebo paclitaxel (tax... carboplatin (pa...	40 Years - 75 Years	Hamamatsu University
Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer	NCT02305758	Untreated Metas...	Veliparib Placebo Modified FOLFIR... FOLFIRI Bevacizumab Fluorouracil in...	18 Years - 99 Years	AbbVie
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma	NCT01335399	Multiple Myelom...	Lenalidomide Dexamethasone Dexamethasone Dexamethasone Dexamethasone Elotuzumab (BMS... Elotuzumab (BMS...	18 Years -	Bristol-Myers Squibb
A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients	NCT00201825	Lung Cancer Non-Small-Cell ...	Capecitabine Docetaxel	18 Years -	Ohio State University Comprehensive Cancer Center
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)	NCT04301739	Triple Negative...	HLX10 nab-paclitaxel,... Placebo	18 Years - 70 Years	Shanghai Henlius Biotech
Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia	NCT03573024	Acute Myeloid L...	Azacitidine Venetoclax	18 Years - 59 Years	University of Colorado, Denver
RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA	NCT01497808	Metastatic Mela...	Ipilimumab Stereotactic Bo...	18 Years -	Abramson Cancer Center at Penn Medicine
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)	NCT04301739	Triple Negative...	HLX10 nab-paclitaxel,... Placebo	18 Years - 70 Years	Shanghai Henlius Biotech
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)	NCT04585815	Carcinoma, Non-...	Sasanlimab Pref... Encorafenib Binimetinib Sasanlimab Axitinib SEA-TGT	18 Years -	Pfizer
A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients	NCT01788137	T-cell Lymphoma... Previously Untr... High Risk	chemotherapy (C... chemotherapy(c-...	18 Years - 70 Years	Sun Yat-sen University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: